Abstract. Background: Oncogenic infection by HPVThe vast majority of cervical cancer incidents are related to a group of 13 high-risk oncogenic human papilloma virus (HPV) types, classified according to sequence similarity, based on established criteria by the International Committee on the Taxonomy of Viruses (1). Types HPV16 and HPV18 represent the most common high-risk types causing cervical cancer (2, 3). Microabrasions on the cervical epithelium surface, allow the entry of HPV and the ensuing infection of the basal membrane epithelium. The initial overexpression of E6 and E7 HPV oncoproteins in the upper layers of the epithelium, leads to the production of viral particles and the establishment of productive infection, associated with the formation of low-grade squamous intraepithelial lesions (LSIL). Subsequent integration of the virus in the host cells, results in progression to high-grade squamous intraepithelial lesions (HSIL), leading eventually to cervical cancer (4-7).Proteomics technologies offer an holistic approach through the identification of many critical proteins, that could facilitate the understanding of biological mechanisms underlying cervical cancer pathogenesis. Proteomic tools have been utilized to study the mechanisms of action of drugs and the discovery of putative biomarkers for cervical cancer (8). However, in the above approaches, only the two-dimensional gel electrophoresis (2DE) coupled to MALDI-TOF has been utilized in most studies so far, whereas the LC-MS/MS technology, a very sensitive technology, has not been widely used. Furthermore, in these few studies where LC-MS/MS was applied, only the intracellular proteome was analyzed, 507